Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-17-002734

Options or other derivatives

  • Chief Business Officer acquired 380,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nolan Lisa · Chief Business Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-01-20 Grant or award : show line 1 in the form Stock Option (right to buy) +315,000 $0.18 2027-01-20 315,000 315,000 D
2017-01-20 Grant or award : show line 2 in the form Restricted Stock Units +65,000 65,000 65,000 D
Loading xslF345X03/form4.xml…